Analyst Insights

Wedbush Reaffirms Neutral On Nuverra, Cuts PT To $11, Following Delay Of TFI Sale

In a research report published yesterday, Wedbush analyst David Rose reaffirmed a Neutral rating on Nuverra Environmental Solutions (NYSE: NES) and cuts his …

Maxim Group Maintains Buy On Keryx; Sees 39% Upside For The Stock

In a research note released this morning, Maxim Group analyst Jason Kolbert maintained a Buy rating on Keryx Biopharmaceuticals (NASDAQ: KERX) with a $24 …

Keurig Green: Recent Share Price Appreciation May Make Relative Outperformance More Challenging, Says William Blair

On Friday, August 22, Keurig Green Mountain (NASDAQ:GMCR) announced a licensing, manufacturing, and distribution agreement with Kraft Foods (NASDAQ:KRFT) to make the Maxwell House, Gevalia, Yuban, and …

Wedbush Maintains Neutral On Amazon Following Acquisition Of Twitch

In a research report published yesterday, Wedbush analyst Michael Pachter maintained a Neutral rating on Amazon (NASDAQ: AMZN) with a $330 price target, in …

Canaccord Maintains Buy On Penn Virginia Following Completion Delays

In a research report issued yesterday to investors, Canaccord analyst Stephen Berman reiterated a Buy rating on Penn Virginia Corporation (NYSE:PVA) with a $23 price …

Roth Capital Maintains Buy On Adept Technology, Lowers PT To $13

In a research note published today, Roth Capital analyst Matt Koranda maintained a Buy rating on Adept Technology Inc. (NASDAQ: ADEP) and decreased …

OraSure: Three Meaningful Catalysts Not Baked Into The Stock, Says Canaccord

In a research note released yesterday, Canaccord analyst Mark Massaro reiterated a Buy rating on OraSure Technologies (NASDAQ:OSUR) shares, and a $11 price target following investor meetings. Massaro commented: …

Wedbush Reiterates Outperform On La Jolla Following Initial Enrollment In LJPC-501 Phase 1/2

In a report issued yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on La Jolla Pharaceutical Co. (NASDAQ:LJPC) with a $45 price target, …

Wedbush Reiterates Underperform On Regado Following Discontinuation Of REGULATE-PCI

In a report issued yesterday, Wedbush analyst Liana Moussatos reiterated an Underperform rating on Regado Bioscoences (NASDAQ:RGDO) and reduced her price target to $1 …

Canaccord Reiterates Buy On Exact Sciences, Raises PT To $23

In a research note released today, Canaccord analyst Mark Massaro reiterated a Buy rating on Exact Sciences (NASDAQ: EXAS) and raised his price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts